• English
  • 简体中文
Login Register
Current Location: Home > FDA Approved Drug Products Feedback Help
-
-
Application Number Application Type Drug Name Active Ingredients Dosage Form/Route Approval Date Company
217694 ANDA TOPIRAMATE TOPIRAMATE CAPSULE;ORAL TWI PHARMS
217248 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2023-03-22 ALKEM LABS LTD
217231 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2023-04-25 DR REDDYS
216167 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2023-02-09 ZYDUS PHARMS
215663 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2022-06-09 AJANTA PHARMA LTD
215638 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2022-07-29 XIAMEN LP PHARM CO
215449 ANDA TOPIRAMATE TOPIRAMATE CAPSULE;ORAL AUROBINDO PHARMA LTD
215414 ANDA TOPIRAMATE TOPIRAMATE TABLET;ORAL 2021-08-26 ASCENT PHARMS INC
214679 NDA EPRONTIA TOPIRAMATE SOLUTION;ORAL 2021-11-05 AZURITY
210278 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2021-02-01 GLENMARK PHARMS LTD
208949 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2022-11-28 ZYDUS
207382 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2017-11-24 ZYDUS
206210 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2023-03-10 ACTAVIS LABS FL
205976 ANDA TOPIRAMATE TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2023-03-01 PAR PHARM
205122 NDA QUDEXY XR TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2014-03-11 UPSHER SMITH LABS
201635 NDA TROKENDI XR TOPIRAMATE CAPSULE, EXTENDED RELEASE;ORAL 2013-08-16 SUPERNUS PHARMS
091185 ANDA TOPIRAMATE TOPIRAMATE TABLET;ORAL 2013-11-25 HIKMA PHARMS
090353 ANDA TOPIRAMATE TOPIRAMATE TABLET;ORAL 2010-09-01 WOCKHARDT
090278 ANDA TOPIRAMATE TOPIRAMATE TABLET;ORAL 2009-03-27 SUN PHARM
090162 ANDA TOPIRAMATE TOPIRAMATE TABLET;ORAL 2009-03-27 UNICHEM LABS LTD